BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 20082192)

  • 1. Novel pharmacological approaches for antiarrhythmic therapy.
    Ravens U
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):187-93. PubMed ID: 20082192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiarrhythmic therapy in atrial fibrillation.
    Ravens U
    Pharmacol Ther; 2010 Oct; 128(1):129-45. PubMed ID: 20624425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current antiarrhythmic drugs: an overview of mechanisms of action and potential clinical utility.
    Singh BN
    J Cardiovasc Electrophysiol; 1999 Feb; 10(2):283-301. PubMed ID: 10090235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A focus on antiarrhythmic properties of ranolazine.
    Vizzardi E; D'Aloia A; Quinzani F; Bonadei I; Rovetta R; Bontempi L; Curnis A; Dei Cas L
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):353-6. PubMed ID: 22492919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atria-selective antiarrhythmic drugs in need of alliance partners.
    Peyronnet R; Ravens U
    Pharmacol Res; 2019 Jul; 145():104262. PubMed ID: 31059791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of cardiac potassium channels.
    Li GR; Dong MQ
    Adv Pharmacol; 2010; 59():93-134. PubMed ID: 20933200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial-selective drugs for treatment of atrial fibrillation.
    Ravens U; Christ T
    Herzschrittmacherther Elektrophysiol; 2010 Dec; 21(4):217-21. PubMed ID: 21082185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient.
    Nantsupawat T; Wongcharoen W; Chattipakorn SC; Chattipakorn N
    Cardiovasc Diabetol; 2020 Nov; 19(1):198. PubMed ID: 33234131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrophysiological characterization and antiarrhythmic efficacy of the mixed potassium channel-blocking antiarrhythmic agent AZ13395438 in vitro and in vivo.
    Jacobson I; Duker G; Florentzson M; Linhardt G; Lindhardt E; Nordkam AK; Åstrand A; Carlsson L
    J Cardiovasc Pharmacol Ther; 2013 May; 18(3):290-300. PubMed ID: 23307834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approaches for pharmacological management of atrial fibrillation.
    Ehrlich JR; Nattel S
    Drugs; 2009; 69(7):757-74. PubMed ID: 19441867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sarcolemmal ion channels and transporters as possible targets for antiarrhythmic and positive inotropic drugs: strategies of the past--perspectives of the future.
    Varro A; Nanasi PP; Acsai K; Virag L; Papp JG
    Curr Pharm Des; 2004; 10(20):2411-27. PubMed ID: 15320753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial-selective K
    Ravens U
    Can J Physiol Pharmacol; 2017 Nov; 95(11):1313-1318. PubMed ID: 28738160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.
    Wirth KJ; Brendel J; Steinmeyer K; Linz DK; Rütten H; Gögelein H
    J Cardiovasc Pharmacol; 2007 Apr; 49(4):197-206. PubMed ID: 17438404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New drugs vs. old concepts: a fresh look at antiarrhythmics.
    Thireau J; Pasquié JL; Martel E; Le Guennec JY; Richard S
    Pharmacol Ther; 2011 Nov; 132(2):125-45. PubMed ID: 21420430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic basis for the antiarrhythmic actions of ranolazine.
    Antzelevitch C; Burashnikov A; Sicouri S; Belardinelli L
    Heart Rhythm; 2011 Aug; 8(8):1281-90. PubMed ID: 21421082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmias and antiarrhythmic drugs.
    Bigger JT
    Adv Intern Med; 1972; 18():251-81. PubMed ID: 4576083
    [No Abstract]   [Full Text] [Related]  

  • 20. Dronedarone: an amiodarone analogue.
    Doggrell SA; Hancox JC
    Expert Opin Investig Drugs; 2004 Apr; 13(4):415-26. PubMed ID: 15102590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.